Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-26

Clinical Trial Update: Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa [Phase 2, Phase 3]

View source ↗

Summary

This is a Phase 2/Phase 3 trial comparing azithromycin plus chloroquine versus artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Africa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Azithromycin (azithromycin)
  • Chloroquine (chloroquine)

Snippet

Sponsor: Pfizer | Conditions: Malaria, Falciparum | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-06-26